A 2022 systematic review published in Frontiers in Psychiatry explores the molecular underpinnings of ketamine’s…
Read More
Microdosing refers to the practice of taking very small, sub-perceptual doses of psychedelic substances such…
A recent randomized controlled trial (RCT) in New Zealand evaluating the R-107 oral ketamine formulation…
A UK-based Phase 2 clinical trial has found that a slow-release oral ketamine tablet significantly…
The Ketamine for Acute Depression and Suicidality (KADS) trial has emerged as a landmark study…
A 2020 review article published in Frontiers in Pharmacology (doi:10.3389/fphar.2020.599721) highlights the expanding role of…
A 2019 randomized clinical trial published in Chronic Stress (PMC6549592) compared the effects of intravenous…
A 2023 study published in the journal Addiction presents a multifaceted investigation into repurposing ketamine…
An innovative study using artificial intelligence (AI) to analyze real-world patient data has found that…
A 2024 narrative review published in Alpha Psychiatry explores ketamine’s growing role in the treatment…
